Sajjad Ghorghanlu
Overview
Explore the profile of Sajjad Ghorghanlu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
135
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ghanaat M, Goradel N, Arashkia A, Ebrahimi N, Ghorghanlu S, Malekshahi Z, et al.
Acta Pharmacol Sin
. 2021 Feb;
42(12):1981-1990.
PMID: 33633364
Although most human papillomavirus (HPV) infections are harmless, persistent infection with high-risk types of HPV is known to be the leading cause of cervical cancer. Following the infection of the...
2.
Goradel N, Baker A, Arashkia A, Ebrahimi N, Ghorghanlu S, Negahdari B
Curr Probl Cancer
. 2020 Aug;
45(1):100639.
PMID: 32828575
Viruses as cancer therapies have attracted attention since the 19th century. Scientists observation that viruses can preferentially lyse cancer cells rather than healthy cells, created the field of oncolytic virology....
3.
Goradel N, Negahdari B, Ghorghanlu S, Jahangiri S, Arashkia A
Pharmacol Ther
. 2020 Jun;
213:107586.
PMID: 32479843
Oncolytic viruses, effectively replicate viruses within malignant cells to lyse them without affecting normal ones, have recently shown great promise in developing therapeutic options for cancer. Adenoviruses (Ads) are one...
4.
Aghaei M, Motallebnezhad M, Ghorghanlu S, Jabbari A, Enayati A, Rajaei M, et al.
J Cell Physiol
. 2019 Feb;
234(10):16768-16778.
PMID: 30807647
Acute myocardial infarction (AMI) is one of the leading causes of morbidity worldwide. Myocardial reperfusion is known as an effective therapeutic choice against AMI. However, reperfusion of blood flow induces...
5.
Safari E, Ghorghanlu S, Ahmadi-Khiavi H, Mehranfar S, Rezaei R, Motallebnezhad M
J Cell Physiol
. 2018 Dec;
234(7):9966-9981.
PMID: 30537008
The immunosuppressive features of tumor lesions participate not only as one of the major players inducing cancer progression but also a big challenge for effective immunotherapy. It has been found...
6.
Enayati A, Yassa N, Mazaheri Z, Rajaei M, Pourabouk M, Ghorghanlu S, et al.
Life Sci
. 2018 Nov;
215:216-226.
PMID: 30419282
Background: Previous studies have shown that proanthocyanidins have cardioprotective effects which are mediated via the release of nitric oxide (NO) ultimately resulting in increasing the antioxidant activity. We have investigated...
7.
Asgharzadeh M, Ghorghanlu S, Rashedi J, Mahdavi Poor B, Khaki-Khatibi F, Moaddab S, et al.
Iran J Allergy Asthma Immunol
. 2016 Jul;
15(3):167-73.
PMID: 27424131
Promoter polymorphism of cytokine genes may lead to inter-individual differences in cytokine levels, therefore, polymorphisms may associate with susceptibility to infectious diseases. In this study, we investigated a possible association...